BILL · 2019–20 SESSION · LATEST VERSION SHB 2335

HB 2335: Opioid use/medications

Increasing access to medications for people with opioid use disorder.

Summary

  • Establishes a registration requirement for remote dispensing sites that use technology to dispense medications approved for the treatment of opioid use disorder.
  • Allows the license of location for a pharmacy to be extended to a registered remote dispensing site.

From the House Bill Report (HB 2335), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · stalled on the House floor
  1. IntroducedJan 13, 2020
  2. Out of committeeFeb 4, 2020
  3. Passed Housestopped here
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Lauren Davis (D-32)
Introduced
January 13, 2020 in the House
Last action
February 21, 2020
Companion bill
SB 6086
Budget
Has a fiscal note
Versions
HB 2335, SHB 2335

AN ACT Relating to increasing access to medications for people with opioid use disorder;

Sponsors

Votes

No recorded floor votes.

History

  1. Returned to Rules Committee for second reading. (SHB 2335)
  2. Returned to Rules Committee for second reading.
  3. Rules Committee relieved of further consideration. Placed on second reading. (SHB 2335)
  4. Rules Committee relieved of further consideration. Placed on second reading.
  5. Referred to Rules 2 Review. (SHB 2335)
  6. Referred to Rules 2 Review.
  7. HCW - Majority; 1st substitute bill be substituted, do pass. (SHB 2335)
  8. HCW - Majority; 1st substitute bill be substituted, do pass.
  9. First reading, referred to Health Care & Wellness.
  10. Prefiled for introduction.

HB 2335 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page